FR2841249A1 - Compositions et methodes pour le dosage de l'apo b48 et de l'apo b100 - Google Patents
Compositions et methodes pour le dosage de l'apo b48 et de l'apo b100 Download PDFInfo
- Publication number
- FR2841249A1 FR2841249A1 FR0207542A FR0207542A FR2841249A1 FR 2841249 A1 FR2841249 A1 FR 2841249A1 FR 0207542 A FR0207542 A FR 0207542A FR 0207542 A FR0207542 A FR 0207542A FR 2841249 A1 FR2841249 A1 FR 2841249A1
- Authority
- FR
- France
- Prior art keywords
- apo
- antibody
- sep
- sample
- produced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Light Receiving Elements (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Steroid Compounds (AREA)
Priority Applications (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0207542A FR2841249A1 (fr) | 2002-06-19 | 2002-06-19 | Compositions et methodes pour le dosage de l'apo b48 et de l'apo b100 |
| JP2004514955A JP2006515561A (ja) | 2002-06-19 | 2003-06-19 | Apo−B48及びApo−B100のアッセイのための組成物及び方法 |
| DK03748180T DK1513878T3 (da) | 2002-06-19 | 2003-06-19 | Sammensætninger og fremgangsmåder til analyse af Apo B48 og Apo B100 |
| ES03748180T ES2283803T3 (es) | 2002-06-19 | 2003-06-19 | Composiciones y procedimientos para la dosificacion de la apo b48 y de la apo b100. |
| DE60312513T DE60312513T2 (de) | 2002-06-19 | 2003-06-19 | Zusammensetzungen und verfahren zum nachweis vom apo-b48 und apo-b100 |
| US10/513,916 US20050152900A1 (en) | 2002-06-19 | 2003-06-19 | Compositions and methods for apo-b48 and apo-b100 assay |
| EP03748180A EP1513878B1 (fr) | 2002-06-19 | 2003-06-19 | Compositions et methodes pour le dosage de l'apo b48 et de l'apo b100 |
| PCT/FR2003/001888 WO2004000884A2 (fr) | 2002-06-19 | 2003-06-19 | Compositions et methodes pour le dosage de l'apo b48 et de l'apo b100 |
| CA002489057A CA2489057A1 (fr) | 2002-06-19 | 2003-06-19 | Compositions et methodes pour le dosage de l'apo b48 et de l'apo b100 |
| AT03748180T ATE356832T1 (de) | 2002-06-19 | 2003-06-19 | Zusammensetzungen und verfahren zum nachweis vom apo-b48 und apo-b100 |
| AU2003267493A AU2003267493A1 (en) | 2002-06-19 | 2003-06-19 | Compositions and methods for apo-b48 and apo-b100 assay |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0207542A FR2841249A1 (fr) | 2002-06-19 | 2002-06-19 | Compositions et methodes pour le dosage de l'apo b48 et de l'apo b100 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR2841249A1 true FR2841249A1 (fr) | 2003-12-26 |
Family
ID=29719858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR0207542A Pending FR2841249A1 (fr) | 2002-06-19 | 2002-06-19 | Compositions et methodes pour le dosage de l'apo b48 et de l'apo b100 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20050152900A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1513878B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2006515561A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE356832T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003267493A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2489057A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE60312513T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1513878T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2283803T3 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2841249A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2004000884A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070207505A1 (en) * | 2004-03-29 | 2007-09-06 | Shibayagi Co., Ltd. | Method for Mesurement of Apoliporotein B-48 and its Use |
| WO2007058588A1 (en) * | 2005-11-18 | 2007-05-24 | T.A.C Thrombosis And Coagulation Aktiebolag | Monoclonal antibodies against apolipoprotein m |
| AP2008004634A0 (en) * | 2006-03-23 | 2008-10-31 | Emelta De Guzman Breyer | Apolipoprotein fingerprinting technique |
| CN104297506B (zh) | 2007-10-02 | 2017-05-03 | 赛拉诺斯股份有限公司 | 模块化现场护理装置及其应用 |
| JP5832723B2 (ja) * | 2009-03-06 | 2015-12-16 | 協和メデックス株式会社 | 可溶性インターロイキン−2受容体定量用標準品 |
| WO2010107380A1 (en) * | 2009-03-17 | 2010-09-23 | Forskarpatent I Syd Ab | Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis and related proteins, peptides and compositions |
| AU2010319323B2 (en) | 2009-11-14 | 2015-01-15 | Cardiovax, Llc | Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis |
| US8506964B2 (en) * | 2010-02-05 | 2013-08-13 | Cardiovax, Llc | Fusion proteins and related compositions, methods and systems for treatment and/or prevention of atherosclerosis |
| JP2013544243A (ja) | 2010-11-12 | 2013-12-12 | シーダース シナイ メディカル センター | 動脈瘤の治療及び/又は予防のための免疫調節方法及びシステム |
| WO2012074725A2 (en) | 2010-11-12 | 2012-06-07 | Cedars-Sinai Medical Center | Immunomodulatory methods and systems for treatment and/or prevention of hypertension |
| CN103477197B (zh) | 2011-01-21 | 2016-08-17 | 提拉诺斯公司 | 样品使用最大化的系统和方法 |
| US20140170735A1 (en) | 2011-09-25 | 2014-06-19 | Elizabeth A. Holmes | Systems and methods for multi-analysis |
| US8475739B2 (en) | 2011-09-25 | 2013-07-02 | Theranos, Inc. | Systems and methods for fluid handling |
| US9632102B2 (en) | 2011-09-25 | 2017-04-25 | Theranos, Inc. | Systems and methods for multi-purpose analysis |
| US9268915B2 (en) | 2011-09-25 | 2016-02-23 | Theranos, Inc. | Systems and methods for diagnosis or treatment |
| US9664702B2 (en) | 2011-09-25 | 2017-05-30 | Theranos, Inc. | Fluid handling apparatus and configurations |
| US10012664B2 (en) | 2011-09-25 | 2018-07-03 | Theranos Ip Company, Llc | Systems and methods for fluid and component handling |
| US9810704B2 (en) | 2013-02-18 | 2017-11-07 | Theranos, Inc. | Systems and methods for multi-analysis |
| US9250229B2 (en) | 2011-09-25 | 2016-02-02 | Theranos, Inc. | Systems and methods for multi-analysis |
| US10401373B1 (en) | 2013-02-18 | 2019-09-03 | Theranos Ip Company, Llc | Systems and methods for analyte testing and laboratory oversight |
| US11008628B1 (en) | 2013-02-18 | 2021-05-18 | Labrador Diagnostics Llc | Systems and methods for analyte testing and laboratory oversight |
| US10422806B1 (en) | 2013-07-25 | 2019-09-24 | Theranos Ip Company, Llc | Methods for improving assays of biological samples |
| US11360107B1 (en) | 2014-02-25 | 2022-06-14 | Labrador Diagnostics Llc | Systems and methods for sample handling |
| CN106053793A (zh) * | 2016-06-20 | 2016-10-26 | 诺莱生物医学研究院(北京)有限公司 | 一种快速检测乳糜血的免疫层析试纸卡及其制备方法 |
| WO2025111449A1 (en) * | 2023-11-21 | 2025-05-30 | Sun Diagnostics, Inc. | Method and reagent to clear turbidity due to elevated triglycerides in a biological specimen |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60193926A (ja) * | 1984-03-15 | 1985-10-02 | Tokyo Daigaku | 単クローン性抗ヒトアポリポ蛋白質b100抗体 |
| JPS617299A (ja) * | 1984-06-20 | 1986-01-13 | Dai Ichi Pure Chem Co Ltd | ヒトアポリポ蛋白b48に高い特異性を有する単クローン性抗体 |
| WO1998056938A1 (en) * | 1997-06-13 | 1998-12-17 | Baylor College Of Medicine | Lipoproteins as nucleic acid vectors |
-
2002
- 2002-06-19 FR FR0207542A patent/FR2841249A1/fr active Pending
-
2003
- 2003-06-19 AU AU2003267493A patent/AU2003267493A1/en not_active Abandoned
- 2003-06-19 DE DE60312513T patent/DE60312513T2/de not_active Expired - Fee Related
- 2003-06-19 CA CA002489057A patent/CA2489057A1/fr not_active Abandoned
- 2003-06-19 DK DK03748180T patent/DK1513878T3/da active
- 2003-06-19 AT AT03748180T patent/ATE356832T1/de not_active IP Right Cessation
- 2003-06-19 WO PCT/FR2003/001888 patent/WO2004000884A2/fr not_active Ceased
- 2003-06-19 ES ES03748180T patent/ES2283803T3/es not_active Expired - Lifetime
- 2003-06-19 US US10/513,916 patent/US20050152900A1/en not_active Abandoned
- 2003-06-19 JP JP2004514955A patent/JP2006515561A/ja active Pending
- 2003-06-19 EP EP03748180A patent/EP1513878B1/fr not_active Expired - Lifetime
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60193926A (ja) * | 1984-03-15 | 1985-10-02 | Tokyo Daigaku | 単クローン性抗ヒトアポリポ蛋白質b100抗体 |
| JPS617299A (ja) * | 1984-06-20 | 1986-01-13 | Dai Ichi Pure Chem Co Ltd | ヒトアポリポ蛋白b48に高い特異性を有する単クローン性抗体 |
| WO1998056938A1 (en) * | 1997-06-13 | 1998-12-17 | Baylor College Of Medicine | Lipoproteins as nucleic acid vectors |
Non-Patent Citations (6)
| Title |
|---|
| DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; CHEN, PEI FENG ET AL: "Primary sequence mapping of human apolipoprotein B-100 epitopes. Comparisons of trypsin accessibility and immunoreactivity and implication for apoB conformation", XP002239296, retrieved from STN Database accession no. 109:144839 CA * |
| DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; INNERARITY, THOMAS L. ET AL: "Structural relationship of human apolipoprotein B48 to apolipoprotein B10", XP002239297, retrieved from STN Database accession no. 108:126927 CA * |
| DATABASE WPI 1985 Derwent World Patents Index; AN 1985-285482, XP002239299, "monoclonal antibody against human apolipoprotein 100 produced by hybridoma created by fusion of mouse spleen and myeloma cells" * |
| DATABASE WPI 1986 Derwent World Patents Index; AN 1986-052892, XP002239298, "Monoclonal antibody has high specificity against human apolipoprotein 48" * |
| EUROPEAN JOURNAL OF BIOCHEMISTRY (1988), 175(1), 111-18, 1988 * |
| JOURNAL OF CLINICAL INVESTIGATION (1987), 80(6), 1794-8, 1987 * |
Also Published As
| Publication number | Publication date |
|---|---|
| ATE356832T1 (de) | 2007-04-15 |
| DK1513878T3 (da) | 2007-07-16 |
| EP1513878A2 (fr) | 2005-03-16 |
| US20050152900A1 (en) | 2005-07-14 |
| WO2004000884A3 (fr) | 2004-04-08 |
| AU2003267493A1 (en) | 2004-01-06 |
| EP1513878B1 (fr) | 2007-03-14 |
| DE60312513T2 (de) | 2007-12-06 |
| DE60312513D1 (de) | 2007-04-26 |
| JP2006515561A (ja) | 2006-06-01 |
| CA2489057A1 (fr) | 2003-12-31 |
| WO2004000884A2 (fr) | 2003-12-31 |
| ES2283803T3 (es) | 2007-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1513878B1 (fr) | Compositions et methodes pour le dosage de l'apo b48 et de l'apo b100 | |
| EP1527101B1 (fr) | Anticorps specifiques du probnp(1-108) et leur utilisation pour le diagnostic de l'insuffisance cardiaque | |
| HUE028331T2 (en) | N-11 truncated β-amyloid monoclonal antibody, preparation, method and use | |
| WO1994004563A1 (fr) | PEPTIDES CONTENANT DES SEQUENCES D'ACIDES AMINES RESPECTIVES SELECTIONNEES PARMI CELLES DE LA LIPOPROTEINE(a) ET DE L'APOLIPOPROTEINE(a), ANTICORPS RECONNAISSANT CES SEQUENCES D'ACIDES AMINES ET PROCEDE D'ANALYSE UTILISANT CES ANTICORPS | |
| WO1990006371A1 (fr) | ANTICORPS MONOCLONAUX ANTI-INTERLEUKINES 1α ET 1β, LEUR PROCEDE DE PRODUCTION ET APPLICATIONS DESDITS ANTICORPS A LA DETECTION DES INTERLEUKINES 1α et 1β ET EN THERAPEUTIQUE | |
| CA2274776C (en) | Method for analyzing annexin v in urine and use thereof | |
| EP2446038B1 (fr) | Sequences, anticorps, procedes et necessaires pour la detection et le dosage in vitro de la periostine, en vue du diagnostic du suivi ou du pronostic de pathologies ou de phenomenes biologiques impliquant la periostine | |
| EP1423707B1 (fr) | Methodes de criblage de molecules utiles pour la prevention des maladies cardiovasculaires | |
| JP2023516171A (ja) | ADM-Gly/バイオADM比が閾値を超える患者においてADM-GlyからバイオADMへの転移を促進するための遊離N末端に結合する抗ADM抗体およびビタミンCとの組合せ | |
| EP0327418B1 (fr) | Procédé immunométrique pour le dosage de particules de lipoprotéine, anticorps monoclonaux anti-Lp(a) et application au diagnostic de l'athérosclérose | |
| JP3018110B2 (ja) | モノクローナル抗体 | |
| JPH1090268A (ja) | 免疫学的粒子凝集反応方法 | |
| EP0667897B1 (fr) | Methode d'immunodosage specifique de la glutathion peroxydase plasmatique humaine | |
| EP1423708B1 (fr) | Compositions et methodes pour le dosage de l'aa4rp | |
| JPH0216997A (ja) | γ−ANPを認識するモノクローナル抗体 | |
| JP2005502029A (ja) | アポbおよび非アポb含有粒子中のアポciiiを測定する新規な方法 | |
| JPH0257177A (ja) | モノクローナル抗体産生細胞ラインおよびモノクローナル抗体 | |
| KR0135708B1 (ko) | 인간 혈중 아포지단백질 비-100(b-100)에 대한 신규 단일클론 항체 및 이들의 생산을 위한 재조합 하이브리도마 세포주 | |
| FR2843395A1 (fr) | Composition et methodes pour le dosage de l'aa4rp | |
| JP2775445B2 (ja) | 抗フェニトインモノクローナル抗体及びそれを産生するハイブリドーマ | |
| JPH0257178A (ja) | モノクローナル抗体産生細胞ラインおよびモノクローナル抗体 |